Results 61 to 70 of about 5,941 (192)

P‐CAB vs. PPI for Upper Gastrointestinal Bleeding Prevention in Patients With Atherothrombotic Disease on Antithrombotic Therapy: A CDM Cohort Study

Alimentary Pharmacology &Therapeutics, Volume 64, Issue 4, Page 499-506, August 2026.
In patients with atherothrombotic disease on antithrombotic therapy, P‐CABs demonstrated a significantly superior protective effect against clinically significant upper GI haemorrhage compared to PPIs (aHR 0.22; p = 0.016). This real‐world study highlights P‐CABs as a more potent gastroprotective strategy for high‐risk populations requiring intensive ...
Min Joo Yoon, Soyoung Lee, Hye‐Kyung Jung, Min‐ho Kim, Suna Yu, Eui Sun Jeong, Chung Hyun Tae   +6 more
wiley   +1 more source

Apple Pomace Pectin for Gastroprotective Nutraceutical Delivery: Structure–Function Relationships and Nano/Microencapsulation Strategies for Gastric Ulcer Management

Food Frontiers, Volume 7, Issue 4, July 2026.
Apple pomace pectin is explored as a sustainable and multifunctional biomaterial for gastric ulcer management. Its unique structural features confer mucoadhesive, anti‐inflammatory, antioxidant, and anti‐Helicobacter pylori activities while enabling nano/microencapsulation of therapeutic agents.
Akash Dhiman, Shefali Arora, Parteek Prasher, Sukanya Chhetri, Pankaj Bhandari, William N. Setzer, Javad Sharifi‐Rad   +6 more
wiley   +1 more source

Rabeprazole-induced acute interstitial nephritis: A case report

National Journal of Physiology, Pharmacy and Pharmacology, 2018
Rabeprazole, a proton-pump inhibitor (PPI), commonly used in the treatment of gastroesophageal reflux disease, a condition caused due to regurgitation of acid from the stomach to the esophagus.
Krishnapriya Raj, Shilpa Raj, Lakshmi R
doaj   +1 more source

A Case of Remarkable Improvement in Dizziness and Lightheadedness in an Elderly Patient Treated With Goshajinkigan

Traditional &Kampo Medicine, Volume 13, Issue 3, December 2026.
Akiko Kikuchi, Rie Ono, Hidehisa Saito, Shin Takayama, Tadashi Ishii   +4 more
wiley   +1 more source

The Diagnostic Challenge of Crohn's Disease With Initial Duodenal Involvement: Two Cases and Literature Review

Immunity, Inflammation and Disease, Volume 14, Issue 7, July 2026.
ABSTRACT Background Upper gastrointestinal Crohn's disease (UGI‐CD) is rare, with an adult prevalence of 0.5%–4.0%. Its nonspecific symptomatology and the absence of clear diagnostic guidelines pose significant diagnostic challenges. Case Presentation We present two patients with UGI‐CD treated at Hainan General Hospital.
Chaochao Chen, Yongrong Li, Yiyao Chen, Zhoutao He, Cheng Lan   +4 more
wiley   +1 more source

Rabeprazole is equivalent to omeprazole in the treatment of erosive gastro-oesophageal reflux disease : a randomised, double-blind, comparative study of rabeprazole and omeprazole 20 mg in acute treatment of reflux oesophagitis, followed by a maintenance open-label, low-dose therapy with rabeprazole [PDF]

, 2005
BACKGROUND: Previous studies have shown similar effects of rabeprazole and omeprazole, when used at the same dose in the treatment of reflux oesophagitis.
F. Pace, S. Casalini, V. Annese, A. Prada, P. Nardini, G. Bianchi Porro, A. Zambelli   +6 more
core   +2 more sources

Benzbromarone as a Novel Candidate for Preventing Alzheimer's Disease: Evidence From Real‐World Data Screening and in Vitro Validation

Clinical and Translational Science, Volume 19, Issue 7, July 2026.
Drug repositioning analysis identifies candidate therapeutic agents for Alzheimer’s diseaseand supports further mechanistic and translational investigation. ABSTRACT Drug development for Alzheimer's disease (AD) remains challenging, with only a 0.4% success rate from Phase I trials to regulatory approval.
Sho Sakagami, Yuya Yoshida, Shota Uemura, Taisei Kumamoto, Ryotaro Tsukamoto, Takumi Nishi, Shimpei Kawano, Kohei Fukuoka, Hanami Ino, Kengo Hamamura, Shigehiro Ohdo, Naoya Matsunaga   +11 more
wiley   +1 more source

14‐Day Vonoprazan–Minocycline Dual Therapy Versus Bismuth‐Containing Quadruple Therapy for Helicobacter pylori Rescue Treatment: A Single‐Center Randomized Controlled Noninferiority Trial

Helicobacter, Volume 31, Issue 4, July/August 2026.
ABSTRACT Background Rescue treatment for Helicobacter pylori infection remains challenging in regions with high antibiotic resistance. Although bismuth‐containing quadruple therapy is widely recommended as an empirical rescue regimen, its medication burden may impair tolerability and adherence.
Tingting Yang, Ruijuan Xin, Yanhong Deng, Jun Liu, Xue Li, Xiaole Guo, Linke Ma, Xiaoming Su, Yanxia Liu, Chengdong Su, Qian Hao, Rui Mu, Xiaofei Li, Pengda Wang, Yanling Li, Xue Zhang, Qingrui Li, Yuting Wu, Shengjuan Hu   +18 more
wiley   +1 more source

Rabeprazole Impedes the Development of Reflux-Induced Esophageal Cancer in a Surgical Rat Model

, 2010
The role of proton pump inhibitors in Barrett's metaplasia and esophageal adenocarcinoma has been an area of controversy. We evaluated the effectiveness of the proton pump inhibitor rabeprazole as a chemoprevention agent in a surgical rat reflux model of
Ohta, Tetsuo, Tetsuo Ohta, Gibson, Michael K., Marti, Guy P., Jiaai Wang, Bonde, Pramod, Mark Duncan, Pramod Bonde, Harmon, John W., Miyashita, Tomoharu, Shah, Furhawn A., Montgomery, Elizabeth A., Furhawn A. Shah, Elizabeth A. Montgomery, John W. Harmon, Tomoharu Miyashita, Guy P. Marti, Duncan, Mark, Wang, Jiaai, Michael K. Gibson   +19 more
core   +1 more source

Comparison of rabeprazole 20 mg vs. omeprazole 20 mg in the treatment of active gastric ulcer--a European multicentre study. The European Rabeprazole Study Group

, 2010
To access publisher full text version of this article. Please click on the hyperlink in Additional Links fieldBACKGROUND: Rabeprazole sodium is the newest member of a class of substituted benzimidazole molecules known as proton pump inhibitors.
Humphries, T J, Beker, J A, Dekkers, C P, Gabryelewicz, A, Thjodleifsson, B, Bell, N E   +5 more
core   +1 more source